Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Expect Strong Q2 - Add to Positions

July 10, 2012 9:16 AM EDT Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Vascular Solutions (NASDAQ: VASC) price target of $15.00.

Analyst, Jason R. Mills, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login